AllTranz Inc. Contract Research Capabilities
AllTranz Inc. is fully accredited and approved for Schedule I-V controlled substances, animal use, and human tissues/blood sample use.
Small Molecule Synthesis
AllTranz has the capabilities to design, synthesize and characterize novel dermal prodrugs for altered delivery rates through the skin as well as, novel intranasal, oral, ophthalmic, buccal, and injectable prodrugs for altered absorption or solubility.
Waters HPLC preparatory system with UV detector
Waters Micromass Quattro Micro API HPLC/MS/MS with photodiode array detector
Agilent HP5890 Gas Chromatograph with Flame Ionization Detector with Agilent 7694 headspace
AllTranz has many capabilities in analytical chemistry to characterize either API or formulated drug product:
HPLC or GC assay development, qualification, or validation
Residual solvent analysis
Development of LC- MS or LC-MS/MS assays for pharmacokinetic studies
Stability indicating method development
Stability testing of API or formulated products:
25°C, 60% R.H.
40°C, 75% R.H.
In vitro Testing
AllTranz has the ability to provide a number of in vitro tests to analyze the physicochemical properties of a compound.
In vitro drug permeation studies in flow through diffusion systems using cells either 1, 1.77, or 6.25 cm2 in diffusional area (special size requests considered).
Human skin (surgical waste or cadaver)
Weanling pig or Yucatan pig
Permeation studies using cultured human skin (EpiDerm) and tracheal/bronchial tissue (EpiAirway) to study: TEER, epithelial potential difference (PD), and TEWL.
In vivo Testing
AllTranz has a number of animal testing models for drug product evaluation following topical application, intranasal application, intravenous administration, and other routes of delivery:
Hairless rats and other rats
Hairless guinea pigs
Yucatan miniature pigs
Barrier function (irritation) studies can be determined by transepidermal water loss (TEWL), colorimeter and impedance.